Accelerant Holdings ARX Q1 2026 Earnings EPS Beat Drives Positive Investor Sentiment DMAC Q1 2026 Earnings Wider Loss Than Expected as Clinical Pipeline Advances GAINN Q1 2026 Earnings EPS Misses Estimates by 88 Stock Unchanged Recursion Pharmaceuticals Q1 2026 Earnings EPS Beat Amidst Pipeline Development BLBD Q1 2026 Earnings EPS Beat Drives Stock Higher on Operational Strength Pearson Q4 2025 Earnings Small EPS Beat Signals Steady Progress